| Full Name | Holly Wall |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 82 Monrovia Ave, Smyrna, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730638735 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | O4-0000489 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Holly Wall, 82 Monrovia Ave, Smyrna, DE 19977-1530 Ph: () - | Holly Wall, 82 Monrovia Ave, Smyrna, DE 19977-1530 Ph: (302) 653-8585 |
News Archive
API Healthcare, the leader in healthcare-specific workforce management solutions, today issued a set of best practices to help hospitals of all sizes effectively prepare for and manage the challenging repercussions of healthcare reform legislation. Industry experts expect this legislation to generate millions of new patients, create a severe nursing shortage and have a significant financial impact on hospitals and other healthcare providers.
Cris Kerr highlights Naltrexone in her latest issue of 'Case Health - Health Success Stories'.
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
Dubbed the "Brilliant 10" by Popular Science, two researchers on the magazine's recently released 2010 list of top young scientists have received funding from the Office of Naval Research (ONR).
New York University College of Dentistry has received a sub-award in the amount of $335,000 from a Small Business Innovation Research (SBIR) Phase II grant from the National Institutes of Health to complete the development of a fully automated self-confirming assay that can simultaneously detect HIV/AIDS antibodies and viral RNA from the AIDS virus in a single specimen.
› Verified 6 days ago
Kim Schulenburg, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Sunnyside Rd, Smyrna, DE 19977 Phone: 302-223-1284 | |
Amanda Marie Schaffner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 80 Monrovia Ave, Smyrna, DE 19977 Phone: 302-659-4330 | |
Adele Chiasson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 121 S School Ln, Smyrna, DE 19977 Phone: 302-653-8588 | |
Erin Sullivan, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 365 N Main St, Smyrna, DE 19977 Phone: 302-653-8589 | |
Mrs. Risa Lee Malone, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 S Main St, Smyrna, DE 19977 Phone: 302-653-8585 | |
Grace Tateoka, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 365 N Main St, Smyrna, DE 19977 Phone: 302-653-8589 | |
Miss Kaitlyn Alyssa Dowd, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 S Main St, Smyrna, DE 19977 Phone: 302-653-3135 Fax: 302-653-2766 |